Locksley Resources (ASX: LKY) hits 99.5% purity antimony trioxide milestone, opening U.S. defense supply chain pathway
How Accenture is using Google Cloud and Wiz to close security blind spots in modern multi-cloud infrastructure
Read More 3 minute read Pharma Industry News Silexion Therapeutics completes key study on SIL-204 in pancreatic cancer models, initial results expected soon Silexion Therapeutics Corp. (NASDAQ: SLXN), a clinical-stage biotechnology company developing RNA interference therapy, has reached a major milestone… byPallavi MadhirajuFebruary 25, 2025